Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Article
  • Published:

Adenovirus-mediated transfer of the p53 family genes, p73 and p51/p63 induces cell cycle arrest and apoptosis in colorectal cancer cell lines: potential application to gene therapy of colorectal cancer

Abstract

p53 gene therapy is being tested clinically for the treatment of human cancer, however, some cancer models (in vivo and in vitro) are resistant to p53. To explore the potential use of two p53 homologues, p73 and p51/p63, in cancer gene therapy, we introduced p53, p73 and p51/p63 into colorectal cancer cell lines via adenoviral vectors, and compared their effects on cell growth. Among 10 cell lines tested, six cell lines displayed a similar response following transduction of p53, p73β or p51A/p63γ; two lines underwent cell-cycle arrest, three lines exhibited apoptosis and one line showed no-effect following transduction. The effect on cell-cycle progression was variable in the other four cell lines. Interestingly, three cell lines were resistant to p53-mediated apoptosis, including two lines having endogenous wild-type p53 alleles, but underwent apoptosis after transduction of p73β or p51A/p63γ. Similar to p53, transduction of p51A/p63γ induced extensive apoptosis when combined with adriamycin or X-radiation in SW480 cells, which are normally resistant to apoptosis. Transduction of p73β and p51A/p63γ also reduced the tumorigenicity of two colorectal cancer cells in vivo. These results suggest that adenovirus-mediated p73β and p51A/p63γ transfer are potential novel approaches for the treatment of human cancers, particularly for tumors that are resistant to p53 gene therapy. Gene Therapy (2001) 8, 1401–1408.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. el-Deiry WS . Regulation of p53 downstream genes Semin Cancer Biol 1998 8: 345–357

    Article  CAS  PubMed  Google Scholar 

  2. Tokino T, Nakamura Y . The role of p53-target genes in human cancer Crit Rev Oncol Hematol 2000 33: 1–6

    Article  CAS  PubMed  Google Scholar 

  3. Vogelstein B et al. Surfing the p53 network Nature 2000 408: 307–310

    Article  CAS  PubMed  Google Scholar 

  4. Hollstein M et al. p53 mutations in human cancers Science 1991 253: 49–53

    Article  CAS  PubMed  Google Scholar 

  5. Levine AJ et al. The p53 tumour suppressor gene Nature 1991 351: 453–456

    Article  CAS  PubMed  Google Scholar 

  6. Clarke AR et al. p53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following gamma-irradiation Oncogene 1994 9: 1767–1773

    CAS  PubMed  Google Scholar 

  7. Merritt AJ et al. The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice Cancer Res 1994 54: 614–617

    CAS  PubMed  Google Scholar 

  8. Roemer K, Friedmann T . Mechanisms of action of the p53 tumor suppressor and prospects for cancer gene therapy by reconstitution of p53 function Ann NY Acad Sci 1994 716: 265–280 discussion 280–262

    Article  CAS  PubMed  Google Scholar 

  9. Polyak K et al. Genetic determinants of p53-induced apoptosis and growth arrest Genes Dev 1996 10: 1945–1952

    Article  CAS  PubMed  Google Scholar 

  10. Roth JA et al. Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer Nat Med 1996 2: 985–991

    Article  CAS  PubMed  Google Scholar 

  11. Swisher SG et al. Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer J Natl Cancer Inst 1999 91: 763–771

    Article  CAS  PubMed  Google Scholar 

  12. Nemunaitis J et al. Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer J Clin Oncol 2000 18: 609–622

    Article  CAS  PubMed  Google Scholar 

  13. Kaghad M et al. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers Cell 1997 90: 809–819

    Article  CAS  PubMed  Google Scholar 

  14. Yang A et al. p63, a p53 homolog at 3q27–29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities Mol Cell 1998 2: 305–316

    Article  CAS  PubMed  Google Scholar 

  15. Osada M et al. Cloning and functional analysis of human p51, which structurally and functionally resembles p53 Nat Med 1998 4: 839–843

    Article  CAS  PubMed  Google Scholar 

  16. Yang A, McKeon F . p63 and p73: p53 mimics, menaces and more Nat Rev Mol Cell Biol 2000 1: 199–207

    Article  CAS  PubMed  Google Scholar 

  17. Jost CA et al. p73 is a human p53-related protein that can induce apoptosis Nature 1997 389: 191–194

    Article  CAS  PubMed  Google Scholar 

  18. Zhu J et al. The potential tumor suppressor p73 differentially regulates cellular p53 target genes Cancer Res 1998 58: 5061–5065

    CAS  PubMed  Google Scholar 

  19. Shimada A et al. The transcriptional activities of p53 and its homologue p51/p63: similarities and differences Cancer Res 1999 59: 2781–2786

    CAS  PubMed  Google Scholar 

  20. Ishida S et al. Adenovirus-mediated transfer of p53-related genes induces apoptosis of human cancer cells Jpn J Cancer Res 2000 91: 174–180

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Irwin MS, Kaelin WG Jr . Role of the newer p53 family proteins in malignancy Apoptosis 2001 6: 17–29

    Article  CAS  PubMed  Google Scholar 

  22. Malkin D et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms Science 1990 250: 1233–1238

    Article  CAS  PubMed  Google Scholar 

  23. Celli J et al. Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome Cell 1999 99: 143–153

    Article  CAS  PubMed  Google Scholar 

  24. Donehower LA et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours Nature 1992 356: 215–221

    Article  CAS  PubMed  Google Scholar 

  25. Yang A et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development Nature 1999 398: 714–718

    Article  CAS  PubMed  Google Scholar 

  26. Mills AA et al. p63 is a p53 homologue required for limb and epidermal morphogenesis Nature 1999 398: 708–713

    Article  CAS  PubMed  Google Scholar 

  27. Yang A et al. p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours Nature 2000 404: 99–103

    Article  CAS  PubMed  Google Scholar 

  28. el-Deiry WS et al. WAF1, a potential mediator of p53 tumor suppression Cell 1993 75: 817–825

    Article  CAS  PubMed  Google Scholar 

  29. Vinyals A et al. Failure of wild-type p53 gene therapy in human cancer cells expressing a mutant p53 protein Gene Therapy 1999 6: 22–33

    Article  CAS  PubMed  Google Scholar 

  30. Gomez-Manzano C et al. Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis Cancer Res 1996 56: 694–699

    CAS  PubMed  Google Scholar 

  31. Harris MP et al. Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutant p53 protein Cancer Gene Ther 1996 3: 121–130

    CAS  PubMed  Google Scholar 

  32. Bookstein R et al. p53 gene therapy in vivo of herpatocellular and liver metastatic colorectal cancer Semin Oncol 1996 23: 66–77

    CAS  PubMed  Google Scholar 

  33. Shinoura N et al. Degree of apoptosis induced by adenovirus-mediated transduction of p53 or p73α depends on the p53 status of glioma cells Cancer Lett 2000 160: 67–73

    Article  CAS  PubMed  Google Scholar 

  34. Fujiwara T et al. Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene Cancer Res 1994 54: 2287–2291

    CAS  PubMed  Google Scholar 

  35. Gallardo D et al. Adenovirus-based transfer of wild-type p53 gene increases ovarian tumor radiosensitivity Cancer Res 1996 56: 4891–4893

    CAS  PubMed  Google Scholar 

  36. Ogawa N et al. Novel combination therapy for human colorectal cancer with adenovirus-mediated wild-type p53 gene transfer and DNA-damaging chemotherapeutic agent Int J Cancer 1997 73: 367–370

    Article  CAS  PubMed  Google Scholar 

  37. Vikhanskaya F et al. p73α overexpression is associated with resistance to treatment with DNA-damaging agents in a human ovarian cancer cell line Cancer Res 2001 61: 935–938

    CAS  PubMed  Google Scholar 

  38. Prabhu NS et al. p73β, unlike p53, suppresses growth and induces apoptosis of human papillomavirus E6-expressing cancer cells Int J Oncol 1998 13: 5–9

    CAS  PubMed  Google Scholar 

  39. Yamano S et al. Induction of transformation and p53-dependent apoptosis by adenovirus type 5 E4orf6/7 cDNA J Virol 1999 73: 10095–10103

    CAS  PubMed  PubMed Central  Google Scholar 

  40. Nigro JM et al. Mutations in the p53 gene occur in diverse human tumour types Nature 1989 342: 705–708

    Article  CAS  PubMed  Google Scholar 

  41. Rodrigues NR et al. p53 mutations in colorectal cancer Proc Natl Acad Sci USA 1990 87: 7555–7559

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Cottu PH et al. Inverse correlation between RER+ status and p53 mutation in colorectal cancer cell lines Oncogene 1996 13: 2727–2730

    CAS  PubMed  Google Scholar 

  43. Jia LQ et al. Screening the p53 status of human cell lines using a yeast functional assay Mol Carcinog 1997 19: 243–253

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Dr Joseph F Costello for critical comments about this manuscript. This research was supported in part by Grants-in-Aid for Cancer Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sasaki, Y., Morimoto, I., Ishida, S. et al. Adenovirus-mediated transfer of the p53 family genes, p73 and p51/p63 induces cell cycle arrest and apoptosis in colorectal cancer cell lines: potential application to gene therapy of colorectal cancer. Gene Ther 8, 1401–1408 (2001). https://doi.org/10.1038/sj.gt.3301538

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3301538

Keywords

This article is cited by

Search

Quick links